Our observations suggested that the increased expression of BIM and BMF that results from SNAI2 knockdown may enhance apoptosis in TPM cancer cells treated with MEK1/2 and HDAC inhibitors (Fig 5a). The gene discussed is BCL2L11; the disease is cancer.